Abstract: A method of vaporising liquefied natural gas (LNG) for measurement of its constituent components may include receiving LNG from a main pipeline into a pressurising device. The method may also include via the pressurising device, pressurising a the LNG beyond a critical pressure thereof. The method may further include directing a first portion of the pressurised LNG to a heater. The method may still further include via the heater, heating the first portion of pressurised LNG beyond a critical temperature thereof, and directing the pressurised and heated LNG to a vaporising device. The method may also include via the vaporising device, depressurising the heated LNG to a pressure below the critical pressure so as to vaporise the LNG.

Abstract: Provided are binding molecules, such as TCRs or antigen binding fragments thereof and antibodies and antigen-binding fragments thereof, such as those that recognize or bind human papilloma virus (HPV) 16, including HPV 16 E6 and HPV 16 E7. Also provided are engineered cells containing such binding molecules, compositions containing the binding molecules or engineered cells, and methods of treatment, such as administration of the binding molecules, engineered cells, or compositions.

Abstract: A method of vaporising liquefied natural gas (LNG) for measurement of its constituent components may include receiving LNG from a main pipeline into a pressurising device. The method may also include via the pressurising device, pressurising a the LNG beyond a critical pressure thereof. The method may further include directing a first portion of the pressurised LNG to a heater. The method may still further include via the heater, heating the first portion of pressurised LNG beyond a critical temperature thereof, and directing the pressurised and heated LNG to a vaporising device. The method may also include via the vaporising device, depressurising the heated LNG to a pressure below the critical pressure so as to vaporise the LNG.

Abstract: The present disclosure is directed to the generation of NK cells (or other lymphocytes) from induced pluripotent cells that have been derived from cells, e.g., developmentally mature T cells, and uses thereof for immunotherapy.

Abstract: CRISPR/Cpf1-related compositions and methods for treatment of cancer.

Abstract: Diagnostic kit comprising an oligonucleotide probe for the mRNA encoding a polypeptide having an amino acid sequence substantially identical to that of SEQ ID NO: 2.

Abstract: Isolated nucleic acid sequence encoding the CD20 gene comprising SEQ ID NO: 5, recombinant vector comprising a nucleic acid sequence placed under the control of one or a plurality of elements required for the expression thereof in a host cell, and method for improving the efficacy of a treatment comprising using a nucleic acid sequence comprising SEQ ID NO: 5.

Abstract: Isolated nucleic acid sequence encoding the CD20 gene comprising SEQ ID NO: 5, recombinant vector comprising a nucleic acid sequence placed under the control of one or a plurality of elements required for the expression thereof in a host cell, and method for improving the efficacy of a treatment comprising using a nucleic acid sequence comprising SEQ ID NO: 5.

Abstract: The present invention relates to the use of anti-human neuropilin-2 antibodies, or of ligands of human neuropilin-2 derived from these antibodies, for obtaining a medicament intended to increase p53 expression and to induce tumor cell apoptosis in the context of an anticancer treatment.

Abstract: The present invention relates in particular to a protein from an alternative splicing of the gene encoding CD20, the nucleic acid sequences encoding the protein according to the invention, a mutated form of the CD20 gene as well as drugs, diagnostic tools, diagnostic methods and treatment methods using the protein and the nucleic acid sequences according to the invention.

Abstract: The present invention relates to the use of anti-human neuropilin-2 antibodies, or of ligands of human neuropilin-2 derived from these antibodies, for obtaining a medicament intended to increase p53 expression and to induce tumour cell apoptosis in the context of an anticancer treatment.

Abstract: A 3-dimensional, token alignment game which can be played by 2 or 3 people and consists of a 6 sided game box inset with 96 small, rotatable, cube shaped game pieces and a detachable, rotatable base. The 96 game pieces are all identical, each having 4 different colored sides and a shaft through the center which is parallel to the colored sides of the game piece. The shafts are inset into the sides of the game box and they allow each game piece to be turned so that only one of the colored sides of the game piece is visible from the outside of the game box. At the start of a game all 96 game pieces are positioned so that only the same, single neutral color is visible on each game piece. Each player then chooses one of the remaining colors as their own. In succession each player turns one neutral colored game piece so that that game piece shows only their color. This procedure is repeated until a player manages to get 5 of their color game pieces in a consecutive horizontal, vertical or diagonal line.